Titleist Asset Management’s AbbVie ABBV Stock Holding History

Titleist Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$686K	Sell	2,724 -1,457	-35%	-$313K	0.05%	238
2026 Q1	$909K	Sell	4,181 -185	-4%	-$41K	0.07%	184
2025 Q4	$998K	Buy	4,366 +918	+27%	+$209K	0.08%	152
2025 Q3	$798K	Buy	3,448 +83	+2%	+$16.9K	0.07%	158
2025 Q2	$625K	Buy	3,365 +1,635	+95%	+$304K	0.06%	178
2025 Q1	$362K	Buy	1,730 +211	+14%	+$41K	0.04%	221
2024 Q4	$270K	Buy	1,519 +302	+25%	+$55.5K	0.03%	265
2024 Q3	$240K	Sell	1,217 -43	-3%	-$8.03K	0.03%	250
2024 Q2	$216K	Buy	1,260 +113	+10%	+$18.7K	0.03%	243
2024 Q1	$209K	Buy	+1,147	New	+$198K	0.04%	240
2023 Q4	–	Sell	-4,469	Closed	-$666K	–	221
2023 Q3	$666K	Buy	4,469 +162	+4%	+$23.8K	0.14%	126
2023 Q2	$580K	Buy	4,307 +845	+24%	+$124K	0.11%	138
2023 Q1	$552K	Buy	+3,462	New	+$529K	0.12%	130

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Titleist Asset Management's ABBV Position: Q2 2026 in Review

Titleist Asset Management reduced its AbbVie (ABBV) stake by 35% in Q2 2026, selling an estimated $313K and leaving 2,724 shares worth $686K. The position accounts for 0.05% of the portfolio, ranked #238.

Titleist Asset Management first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $998K in Q4 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Titleist Asset Management held 2,724 shares of AbbVie worth $686K as of Q2 2026.
Titleist Asset Management sold 1,457 AbbVie shares in Q2 2026, an estimated $313K.
AbbVie made up 0.05% of Titleist Asset Management's portfolio in Q2 2026, its #238 holding.
Titleist Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Titleist Asset Management's AbbVie position peaked at $998K in Q4 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Titleist Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.